Berenson Acquisition I in its annual report filed May 31 include an audit opinion from its independent registered public accounting firm that raises “substantial doubt about our ability to continue as a going concern for one year from the issuance of these financial statements.”
As of Dec. 31, 2023, the SPAC reported $115,435 of cash in its operating account and a working capital deficit of $4,004,819. “We incurred and expect to continue to incur significant costs in pursuit of its initial business combination,” Berenson I said in the filng.
Berenson I announced a deal with Custom Health in December at a $185 million pre-money equity value.
Custom Health provides a comprehensive technology-enabled medication management and managed care solution, resulting in 98% medication adherence for its patients across the United States and Canada. Read more.
